Cystic Fibrosis Clinical Trials in Minneapolis, Minnesota

4 studies are recruiting for cystic fibrosis in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

    The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.

    Stage
    Not phased
    Ages
    3 to 18
    Site
    Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota
    Locations
    33 in total
    Run by
    University of Washington, the Collaborative Health Studies Coordinating Center

    See if you can join NCT06654752 on ClinicalTrials.gov

  2. Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

    This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children with cystic fibrosis (CF).

    Stage
    Not phased
    Ages
    Up to 10
    Site
    Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota
    Locations
    35 in total
    Run by
    Sonya Heltshe

    See if you can join NCT04509050 on ClinicalTrials.gov

  3. Health Outcomes of Parents With Cystic Fibrosis-Aim 2

    The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators. The investigators will collect physical and mental health data to comprehensively evaluate the im…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Locations
    18 in total
    Run by
    University of Pittsburgh

    See if you can join NCT06296394 on ClinicalTrials.gov

  4. A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

    The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to in…

    Stage
    Not phased
    Ages
    12 and older
    Site
    The Minnesota Cystic Fibrosis Center, Minneapolis, Minnesota
    Locations
    68 in total
    Run by
    Nicole Hamblett

    See if you can join NCT06504589 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.